Patents by Inventor Sergazy M. Adekenov

Sergazy M. Adekenov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic uses of arglabin in combination with other chemotherapy agents
    Patent number: 6770673
    Abstract: Compositions and kits containing a first chemotherapeutic agent that includes arglabin or a derivative thereof and a second chemotherapeutic agent are described. The compositions and kits are effective for treating cancer in a human patient. Methods for suppressing tumor growth in a human and for reducing the immunodepressive effects of chemotherapeutic agents are also described.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: August 3, 2004
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Pharmaceutical compositions of arglabin and arglabin derivatives
    Patent number: 6693127
    Abstract: Pharmaceutical compositions containing arglabin and arglabin derivatives are described. The compositions can be in unit dosage form and are useful for the treatment of cancer in humans.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: February 17, 2004
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Farnesyl-protein transferase inhibitors
    Patent number: 6429203
    Abstract: Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described.
    Type: Grant
    Filed: April 18, 2000
    Date of Patent: August 6, 2002
    Assignee: International Phytochemistry Research Labs, Ltd.
    Inventors: Tattym E. Shaikenov, Sergazy M. Adekenov
  • Farnesyl-protein transferase inhibitors
    Patent number: 6268394
    Abstract: Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: July 31, 2001
    Assignee: International Phytochemistry Research Labs, Ltd.
    Inventors: Tattym E. Shaikenov, Sergazy M. Adekenov
  • Farnesyl-protein transferase inhibitors
    Patent number: 6262110
    Abstract: Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting fanesyl-protein transferase activity are also described.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: July 17, 2001
    Assignee: International Phytochemistry Research Labs, Ltd.
    Inventors: Tattym E. Shaikenov, Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 6197767
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: March 6, 2001
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 6080741
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: June 27, 2000
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Farnesyl-protein transferase inhibitors
    Patent number: 6051565
    Abstract: Substantially pure preparations of phosphosesquiterpenes are described. The compounds inhibit farnesyl-protein transferase activity and are useful for the treatment of cancer. Methods for inhibiting farnesyl-protein transferase activity are also described.
    Type: Grant
    Filed: February 25, 1998
    Date of Patent: April 18, 2000
    Assignee: International Phytochemistry Research Labs, Ltd.
    Inventors: Tattym E. Shaikenov, Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 6020365
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: February 1, 2000
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 5902809
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: May 11, 1999
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov